Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nifuratel and nystatin vaginal soft capsules equivalence trial
CTR20232169Phase 3Completed
- Sponsor
- Zhengrui Pharmaceutical
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nifuratel + nystatin in trichomoniasis (trich), vulvovaginal candidiasis (VVC), bacterial vaginosis (BV), mixed vaginitis, sponsored by Zhengrui Pharmaceutical. Started Jul 2023; status: completed.
02
Drugs
nifuratel + nystatin
03
Conditions
trichomoniasis (trich)vulvovaginal candidiasis (VVC)bacterial vaginosis (BV)mixed vaginitis
Beyond the preview
Go deeper on CTR20232169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232169.